CompanyPTGXNasdaqNewark, CA

Protagonist Therapeutics, Inc.

Protagonist Therapeutics discovers and develops peptide therapeutics using a proprietary platform.

SEC EDGAR ClinicalTrials.gov protagonist-inc.com

6-KAug 31Latest SEC filing, period to Aug 28

Aug 5Latest story

August 2026

Protagonist posts Q2 2026 profit as ICOTYDE launch and rusfertide review advance

Aug 5Quarterly updateicotrokinra Johnson & Johnson